Table 1.
Variable | Cannabis Use Disorder (CUD) Symptoms | Overall (N=85) | F or χ2 | p | |||
---|---|---|---|---|---|---|---|
| |||||||
None (0–1 symptom) (n=5) | Mild (2–3 symptoms) (n=25) | Moderate (4–5 symptoms) (n=28) | Severe (6+ symptoms) (n=27) | ||||
Age | |||||||
Observed Range | 18–24 | 18–24 | 15–24 | 15–24 | 15–24 | ||
M (SD) | 20.0 (2.3) | 20.3 (1.7) | 20.1 (1.9) | 18.9 (2.3) | 19.8 (2.1) | 2.67 | .053 |
Sex, # (%) female | 3 (60.0) | 15 (60.0) | 10 (35.7) | 13 (48.1) | 41 (48.2) | 3.42 | .331 |
Race, # (%)a | |||||||
White or Caucasian | 3 (60.0) | 13 (52.0) | 20 (71.4) | 11 (40.7) | 47 (55.3) | 17.02 | .318 |
Black or African-American | 1 (20.0) | 7 (28.0) | 6 (21.4) | 11 (40.7) | 25 (29.4) | ||
Other | 1 (20.0) | 4 (16.0) | 1 (3.6) | 1 (3.7) | 7 (8.2) | ||
Hispanic, # (%) | 1 (20.0) | 5 (20.0) | 1 (3.6) | 8 (29.6) | 15 (17.6) | 6.60 | .086 |
Baseline, 90-day cannabis-use levelsb | |||||||
% use days, M (SD) | 36.7 (27.12) | 58.6 (29.5) | 76.8 (19.8) | 79.4 (21.5) | 69.9 (27.0) | 6.87 | <.001 |
Grams per use day, M (SD) | 0.25 (0.17) | 0.64 (0.73) | 0.68 (0.43) | 0.70 (0.43) | 0.65 (0.53) | 1.05 | .374 |
Note.
Six participants did not identify with a race option, including “other.” Of these, 5 indicated Hispanic or Latino ethnicity.
Baseline cannabis use derived from the 90-day Timeline Follow-Back interview administered prior to in vivo assessments.